VIRGINIA RETIREMENT SYSTEMS ET Al Purchases 17,400 Shares of Maximus, Inc. $MMS

VIRGINIA RETIREMENT SYSTEMS ET Al grew its position in shares of Maximus, Inc. (NYSE:MMSFree Report) by 404.7% during the 4th quarter, Holdings Channel reports. The institutional investor owned 21,700 shares of the health services provider’s stock after buying an additional 17,400 shares during the quarter. VIRGINIA RETIREMENT SYSTEMS ET Al’s holdings in Maximus were worth $1,873,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently added to or reduced their stakes in MMS. Royal Bank of Canada increased its position in Maximus by 146.2% during the 1st quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider’s stock worth $1,345,000 after buying an additional 11,716 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Maximus by 0.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after buying an additional 221 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Maximus by 7.0% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider’s stock worth $12,321,000 after buying an additional 11,754 shares during the period. Jane Street Group LLC increased its position in Maximus by 941.2% during the 1st quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider’s stock worth $6,701,000 after buying an additional 88,835 shares during the period. Finally, Sivia Capital Partners LLC bought a new position in Maximus during the 2nd quarter worth $204,000. Institutional investors own 97.21% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently issued reports on the company. Weiss Ratings lowered Maximus from a “buy (b)” rating to a “hold (c+)” rating in a report on Tuesday, February 24th. Zacks Research lowered Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, April 27th. Finally, Wall Street Zen lowered Maximus from a “buy” rating to a “hold” rating in a report on Monday, February 23rd. Two equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has an average rating of “Hold”.

Read Our Latest Analysis on MMS

Maximus Stock Performance

MMS opened at $59.16 on Friday. The firm has a market cap of $3.11 billion, a P/E ratio of 8.86 and a beta of 0.60. Maximus, Inc. has a 52-week low of $57.32 and a 52-week high of $100.00. The company has a debt-to-equity ratio of 0.87, a quick ratio of 2.21 and a current ratio of 2.21. The business’s fifty day moving average is $67.07 and its 200-day moving average is $78.95.

Maximus (NYSE:MMSGet Free Report) last released its quarterly earnings data on Thursday, May 7th. The health services provider reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.98 by $0.09. The business had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.32 billion. Maximus had a return on equity of 25.10% and a net margin of 7.02%.Maximus’s revenue was down 4.1% compared to the same quarter last year. During the same period last year, the firm posted $2.01 earnings per share. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. Sell-side analysts expect that Maximus, Inc. will post 8.4 EPS for the current fiscal year.

Maximus Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 1st. Investors of record on Friday, May 15th will be paid a $0.33 dividend. The ex-dividend date of this dividend is Friday, May 15th. This represents a $1.32 annualized dividend and a yield of 2.2%. Maximus’s dividend payout ratio (DPR) is 19.76%.

Insiders Place Their Bets

In related news, Director Jan Madsen sold 742 shares of the firm’s stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total value of $53,609.50. Following the sale, the director directly owned 20,795 shares of the company’s stock, valued at $1,502,438.75. This trade represents a 3.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.80% of the stock is owned by company insiders.

Maximus Company Profile

(Free Report)

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

Further Reading

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSFree Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.